Why the study?
Does combined thrombolysis and angioplasty improve long-term outcomes in a patient with superior vena cava syndrome due to permanent transvenous pacemaker electrodes?
Does combined thrombolysis and angioplasty improve long-term outcomes in a patient with superior vena cava syndrome due to permanent transvenous pacemaker electrodes?
Combined local thrombolytic therapy and balloon venoplasty may be an effective and durable treatment for superior vena cava syndrome caused by permanent transvenous pacemaker electrodes.
May support durable benefit of combined thrombolysis and venoplasty in pacemaker-related SVC syndrome; hypothesis-generating case report requiring prospective validation.
Superior vena cava syndrome is a rare complication of permanent transvenous pacing electrodes. Multiple treatment options are available, namely thrombolytics, venoplasty, stenting, surgery, and combinations of the above, yet initially the optimal approach is uncertain. Whether plain balloon angioplasty provides durable and satisfactory long-term results is equally uncertain. The authors report a patient treated with a combination of local thrombolytic therapy and balloon venoplasty with good long-term outcome at two years of follow-up.
No takes yet. Share an insight, caveat, or question.
Tan et al. (2000) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: